GLOW 10 vials 70mg

What Is the GLOW Blend

The GLOW blend unites three of the most extensively studied tissue-repair peptides in preclinical literature. BPC-157 (Body Protection Compound-157) targets angiogenesis and connective tissue signaling. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) drives collagen synthesis and extracellular matrix remodeling. TB-500 (a Thymosin Beta-4 fragment) promotes actin polymerization and cell migration.

Together, these compounds address complementary mechanisms that single-peptide protocols may not fully engage. Labs studying multi-pathway skin regeneration, wound healing, or connective tissue repair buy GLOW blend for exactly that reason. See our GLOW vs KLOW peptide blend comparison guide for how the two PSPeptides formulations differ.

Key Research Applications

Labs buy GLOW blend for five core research areas:

·         Skin and collagen research: GHK-Cu and BPC-157 together support studies on collagen type I/III upregulation, elastin production, and dermal matrix integrity.

·         Wound healing models: All three peptides have demonstrated accelerated wound closure in excisional, incisional, and burn models in published preclinical literature.

·         Connective tissue repair: BPC-157 and TB-500 both show tendon fibroblast outgrowth activity, making this blend relevant for musculoskeletal repair research.

·         Anti-inflammatory pathways: GHK-Cu modulates NF-κB signaling while BPC-157 interacts with the nitric oxide system, providing a multi-target anti-inflammatory research model.

·         Angiogenesis studies: BPC-157 activates VEGFR2, while TB-500 sequesters G-actin to promote endothelial cell migration, supporting vascularization research.